OverviewChartNewsTraderScreen

Goldman Sachs Knock-Out RHHVF/  DE000GJ2YWR6  /

EUWAX
2024-09-03  9:42:50 AM Chg.- Bid10:00:27 PM Ask10:00:27 PM Underlying Strike price Expiration date Option type
0.600EUR - -
Bid Size: -		 -
Ask Size: -		 Roche Holding Ltd 278.7644 - 2078-12-31 Call
GlobeNewswire 09-01 Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer
TeleTrader 07-25 Europe lower premarket as earnings pour in
TeleTrader 07-25 Roche's H1 sales at 29.85 billion Swiss francs
GlobeNewswire 06-13 Pliant Therapeutics Announces Appointment of Steve Krognes to Board of Directors
GlobeNewswire 06-11 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
TeleTrader 05-27 Roche shuffles its executive committee
TeleTrader 05-16 Roche notes progress in obesity drug trial
TeleTrader 04-24 Roche's logs 14.4 billion Swiss francs in Q1 sales
TeleTrader 02-01 Roche's 2023 sales increase 1% to 58.7B Swiss francs
TeleTrader 2023-12-04 Roche to buy Carmot Therapeutics for $2.7B
TeleTrader 2023-10-23 Roche to buy Telavant for $7.1 billion
TeleTrader 2023-07-27 Roche's sales fall 8% ito 29.8B Swiss francs in H1
TeleTrader 2023-04-26 Roche posts sales of 15.3B Swiss francs in Q1
TeleTrader 2023-02-02 Roche's 2022 sales stable at 63.28B Swiss francs
TeleTrader 2022-12-12 Roche Pharmaceuticals CEO leaves the company
TeleTrader 2022-10-18 Roche's sales down 6% to 14.7B Swiss francs in Q3
TeleTrader 2022-07-21 Roche's H1 group sales up 5% to 32.3B Swiss francs
TeleTrader 2022-04-25 Roche's Q1 sales up 11% to $17.17 billion
TeleTrader 2022-02-03 Europe opens mixed with ECB's interest rates call in focus
TeleTrader 2022-02-03 Roche's 2021 sales up by 8% to 62.8B Swiss francs
TeleTrader 2021-12-27 Switzerland approves use of Roche COVID treatment
TeleTrader 2021-11-04 Novartis to sell stake in Roche for $20.7 billion
TeleTrader 2021-09-09 Roche acquires long-term biotech partner
TeleTrader 2021-07-22 Roche tops estimates with H1 sales at 30.71B Swiss francs
GlobeNewswire 2021-07-12 Atsena Therapeutics Appoints Jennifer Wellman to Board of Directors